Symbol="ENTX"
AssetType="Common Stock"
Name="Entera Bio Ltd"
Description="Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel."
CIK="1638097"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="24422700"
EBITDA="-11789000"
PERatio="None"
PEGRatio="None"
BookValue="0.35"
DividendPerShare="0"
DividendYield="0"
EPS="-0.41"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-179.56"
ReturnOnAssetsTTM="-0.437"
ReturnOnEquityTTM="-0.77"
RevenueTTM="66000"
GrossProfitTTM="33000"
DilutedEPSTTM="-0.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.915"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="63.37"
PriceToBookRatio="1.262"
EVToRevenue="13.56"
EVToEBITDA="-0.277"
Beta="1.846"
num_52WeekHigh="2"
num_52WeekLow="0.472"
num_50DayMovingAverage="0.855"
num_200DayMovingAverage="0.862"
SharesOutstanding="28814000"
DividendDate="None"
ExDividendDate="None"
symbol="ENTX"
open="0.86"
high="0.87"
low="0.83"
price="0.85"
volume="31277.00"
latest_trading_day="2023-07-14"
previous_close="0.85"
change="-0.00"
change_percent="-0.2824%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="157453"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0062.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="625"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
